National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources (Members Only
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

National Comprehensive Cancer Network (NCCN) Virtual Reimbursement Resource Room


Patient and Payment Assistance

The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians and others that work with patients with cancer. As a response to these ongoing challenges, help is available through the NCCN Virtual Reimbursement Resource Room.

Select a cancer or supportive care indication or select a reimbursement program below to learn about reimbursement help and services available to you to help your practice mitigate reimbursement challenges.

Download the NCCN Reimbursement Resource App for Smartphones and Tablets

Download the NCCN Virtual Reimbursement Resource Room Guide

The NCCN Reimbursement Resource FREE App for Smartphones and Tablets

Now available for Apple and Android smartphones and tablets! As a response to these ongoing challenges, help is available through the NCCN Reimbursement Resource App; users are able to search for available resources and payment assistance programs.

Information on resources available are listed under three different tabs entitled: Search by Cancer Type or Supportive Care Indication, Search by Drug Name (brand or generic), and Search by Reimbursement or Assistance Program.


The NCCN Virtual Reimbursement Resource Guide

A printer-friendly 23 page resource to empower patients with cancer and their caregivers as you help them navigate the challenging reimbursement landscape.



Acute Promyelocytic Leukemia (APL)

Advanced Melanoma

Advanced Gastric or GEJ Cancer

Advanced MSI-H/dMMR Cancers

Advanced Urothelial Carcinoma

AIDS Related Kaposi's Sarcoma

Anaplastic Large Cell Carcinoma

Basal Cell Carcinoma

Bladder Cancer

Bone Cancer

Bone Metastases

Breast Cancer

Castrate Resistant Prostate Cancer

Chemotherapy-Induced Nausea and Vomiting (CINV)

Chronic Lymphocytic Leukemia

Chronic Myelogenous Leukemia (CML)

Colon Cancer

Gastric Cancer

Gastroesophageal Junction Cancer

Gastrointestinal Stromal Tumor (GIST)


Head and Neck Cancers

Hodgkin's Lymphoma

Kidney Cancer

Mantle Cell Lymphoma


Metastatic Breast Cancer

Metastatic Colorectal Cancer

Metastatic Non-Small Cell Lung Cancer

Multicentric Castleman's Disease

Multiple Myeloma

Mycosis Fungoides/Sezary Syndrome

Myelodysplastic Syndromes


Neuroendocrine Tumors

Neuroendocrine Tumors of Pancreatic Origin


Non-Hodgkin's Lymphomas

Non-Melanoma Cancers

Non-Small Cell Lung Cancer

Ovarian Cancer

Pancreatic Adenocarcinoma

Peripheral T-Cell Lymphoma

Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Prevention and Treatment of Cancer-Related Infections

Prostate Cancer

Rectal Cancer

Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Refractory if Relapsed Classical Hodgkin Lymphoma

Renal Cell Carcinoma

Soft Tissue Sarcoma

Thyroid Cancer

Waldenström's Macroglobulinemia


Industry: Provide needed information on reimbursement programs and service available

For information on participating in the NCCN Reimbursement Resource Room or other support opportunities, please contact Jennifer Tredwell at